Position in LH
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$133,421,680
+$49,890,673 QoQ
Shares Held
476,506
+52.2% QoQ
Ownership
0.588%
of shares outstanding
% of Portfolio
0.48%
of 13F equity value
Holder Rank
#40
of 1,040 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 48%
Shared 17%
None 35%
Common Shares in LH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026EARNEST PARTNERS LLC holds $949,661,041 across 7 Diagnostics & Research names. LH ranks #4 (14.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CRL |
Charles River Laboratories International, Inc.
|
1,120,011 | $254,007,294 | |
| 2 | ICLR |
Icon PLC
|
1,242,639 | $215,858,820 | |
| 3 | QGEN |
Qiagen N.V.
|
4,573,455 | $178,822,090 | |
| 4 | LH |
Labcorp Holdings Inc.
This page
|
476,506 | $133,421,680 | |
| 5 | IQV |
Iqvia Holdings Inc.
|
548,088 | $105,901,563 | |
| 6 | A |
Agilent Technologies, Inc.
|
451,170 | $59,928,911 | |
| 7 | WAT |
Waters Corp /De/
|
4,588 | $1,720,683 |
All Filings in LH
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $133,421,680 | 476,506 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $83,531,007 | 313,073 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $80,515,921 | 320,934 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $92,917,016 | 323,685 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $87,017,864 | 331,484 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $76,771,150 | 329,858 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $77,676,417 | 338,725 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $77,565,438 | 347,080 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $65,992,187 | 324,270 | Shares | Sole | 2024-08-14 | |
| No filing history on record for this holder in this stock. | ||||||